Hainan Huluwa Pharmaceutical Group Co Ltd. Stock Analysis 605199.SS

Hainan Huluwa Pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of proprietary Chinese medicines and chemical reagent. The company is headquartered in Haikou, Hainan and currently employs 1,451 full-time employees. The company went IPO on 2020-07-10. The firm's products cover the fields of children's medicines, nutritional supplements, health foods, special medical foods, medical devices and others. The firm's main products include Xiaoer Feire Kechuan Granules, Changyanning Granules/Capsules, Keke Tablets and others. The firm's pharmaceutical business includes respiratory system, digestive system, anti-infection and nutritional supplements. The firm sells its products under the Huluwa brand. The firm mainly operates its businesses in the domestic market.